Clinical Trial Update: Mechanism of Class II Correction With Fixed Lingual Mandibular Growth Modificator (FLMGM) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the Fixed Lingual Mandibular Growth Modificator (FLMGM) for correcting Class II Division 1 malocclusion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Class Ii Division Malocclusion

Drugs mentioned

• Fixed Lingual Mandibular Growth Modificator (FLMGM)

Snippet

Sponsor: Damascus University | Conditions: Class II Division 1 Malocclusion | Phase 2 | Status: COMPLETED